|
Status |
Public on Jan 17, 2020 |
Title |
Anti-inflammatory properties of low dose epirubicin on human macrophages |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
Low-dose epirubicin at non-cytotoxic doses down regulated NLRP3 inflammasome components and reduced the release of proinflammatory cytokines. These anti-inflammatory effects were a result of global transcriptional suppression of LPS-dependent genes.
|
|
|
Overall design |
THP-1 cells were differentiated to macrophages and cells were treated with or without epirubicin (0.25 μg/ml) for 24h and with or without LPS (100 ng/ml) for three hours resulting in four treatment conditions (1. -EPI/- LPS; 2. –EPI/+LPS; 3. +EPI/-LPS; 4. +EPI/+LPS). RNA was isolated and microarray analysis was performed by a commercial transcriptomics provider. Expression analysis was performed using Transcriptome analysis concole (TAC).
|
|
|
Contributor(s) |
Stengel S, Bruns T |
Citation(s) |
31905600 |
|
Submission date |
Sep 03, 2019 |
Last update date |
Mar 09, 2020 |
Contact name |
Sven Stengel |
E-mail(s) |
Stengel2010@googlemail.com
|
Organization name |
Jena University Hospital
|
Department |
Clinic for Internal Medicine IV
|
Lab |
Gastroenterology, Hepatology and Infectiology
|
Street address |
Am Klinikum 1
|
City |
Jena |
ZIP/Postal code |
07747 |
Country |
Germany |
|
|
Platforms (1) |
GPL24324 |
[Clariom_S_Human_HT] Affymetrix Clariom S Assay HT, Human (Includes Pico Assay) |
|
Samples (8)
|
GSM4057493 |
THP1; EPI 0 ug/ml; LPS 100 ng/ml; dup2 |
GSM4057494 |
THP1; EPI 0.25 ug/ml; LPS 0 ng/ml; dup1 |
GSM4057495 |
THP1; EPI 0.25 ug/ml; LPS 0 ng/ml; dup2 |
GSM4057496 |
THP1; EPI 0.25 ug/ml; LPS 100 ng/ml; dup1 |
GSM4057497 |
THP1; EPI 0.25 ug/ml; LPS 100 ng/ml; dup2 |
|
Relations |
BioProject |
PRJNA563607 |